These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12618643

  • 1. Effect of tiered prescription copayments on the use of preferred brand medications.
    Rector TS, Finch MD, Danzon PM, Pauly MV, Manda BS.
    Med Care; 2003 Mar; 41(3):398-406. PubMed ID: 12618643
    [Abstract] [Full Text] [Related]

  • 2. The effect of incentive-based formularies on prescription-drug utilization and spending.
    Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG.
    N Engl J Med; 2003 Dec 04; 349(23):2224-32. PubMed ID: 14657430
    [Abstract] [Full Text] [Related]

  • 3. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
    Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D, Dirstine J, Avorn J, Asch SM.
    Arch Intern Med; 2006 Feb 13; 166(3):332-7. PubMed ID: 16476874
    [Abstract] [Full Text] [Related]

  • 4. Impact of patient and plan design factors on switching to preferred statin therapy.
    Cox ER, Kulkarni A, Henderson R.
    Ann Pharmacother; 2007 Dec 13; 41(12):1946-53. PubMed ID: 17971409
    [Abstract] [Full Text] [Related]

  • 5. A bitter pill: formulary variability and the challenge to prescribing physicians.
    Shrank WH, Ettner SL, Glassman P, Asch SM.
    J Am Board Fam Pract; 2004 Dec 13; 17(6):401-7. PubMed ID: 15575031
    [Abstract] [Full Text] [Related]

  • 6. Relationship between generic and preferred-brand prescription copayment differentials and generic fill rate.
    Mager DE, Cox ER.
    Am J Manag Care; 2007 Jun 13; 13(6 Pt 2):347-52. PubMed ID: 17567235
    [Abstract] [Full Text] [Related]

  • 7. Incentive formularies and changes in prescription drug spending.
    Landon BE, Rosenthal MB, Normand SL, Spettell C, Lessler A, Underwood HR, Newhouse JP.
    Am J Manag Care; 2007 Jun 13; 13(6 Pt 2):360-9. PubMed ID: 17567237
    [Abstract] [Full Text] [Related]

  • 8. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL, Cox ER.
    Am J Manag Care; 2008 Dec 13; 14(12):813-8. PubMed ID: 19067498
    [Abstract] [Full Text] [Related]

  • 9. Consumer response to dual incentives under multitiered prescription drug formularies.
    Gilman BH, Kautter J.
    Am J Manag Care; 2007 Jun 13; 13(6 Pt 2):353-9. PubMed ID: 17567236
    [Abstract] [Full Text] [Related]

  • 10. Impact of statin copayments on adherence and medical care utilization and expenditures.
    Gibson TB, Mark TL, Axelsen K, Baser O, Rublee DA, McGuigan KA.
    Am J Manag Care; 2006 Dec 13; 12 Spec no.():SP11-9. PubMed ID: 17173486
    [Abstract] [Full Text] [Related]

  • 11. Do consumers' attitudes predict prescription purchasing behavior?
    Nair KV.
    Manag Care Interface; 2003 Jun 13; 16(6):22-7, 55. PubMed ID: 12841073
    [Abstract] [Full Text] [Related]

  • 12. Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs.
    Briesacher B, Kamal-Bahl S, Hochberg M, Orwig D, Kahler KH.
    Arch Intern Med; 2003 Jun 13; 164(15):1679-84. PubMed ID: 15302639
    [Abstract] [Full Text] [Related]

  • 13. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.
    Landsman PB, Yu W, Liu X, Teutsch SM, Berger ML.
    Am J Manag Care; 2005 Oct 13; 11(10):621-8. PubMed ID: 16232003
    [Abstract] [Full Text] [Related]

  • 14. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ, Romeis JC.
    Med Care; 2003 Dec 13; 41(12):1331-42. PubMed ID: 14668666
    [Abstract] [Full Text] [Related]

  • 15. Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors.
    Wang YR, Pauly MV.
    Manag Care Interface; 2005 Aug 13; 18(8):39-45. PubMed ID: 16127891
    [Abstract] [Full Text] [Related]

  • 16. The effects of prescription drug copayments on statin adherence.
    Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S.
    Am J Manag Care; 2006 Sep 13; 12(9):509-17. PubMed ID: 16961440
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.
    Hansen RA, Shaheen NJ, Schommer JC.
    Clin Ther; 2005 Sep 13; 27(9):1478-87. PubMed ID: 16291421
    [Abstract] [Full Text] [Related]

  • 18. Controlling prescription drug expenditures: a report of success.
    Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA.
    Am J Manag Care; 2007 Aug 13; 13(8):473-80. PubMed ID: 17685828
    [Abstract] [Full Text] [Related]

  • 19. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE, Siracuse MV, Garis RI.
    Res Social Adm Pharm; 2009 Jun 13; 5(2):133-42. PubMed ID: 19524861
    [Abstract] [Full Text] [Related]

  • 20. Drug benefit generosity and essential medication use among Medicare-eligible retirees.
    Doshi JA, Polsky D.
    Am J Manag Care; 2007 Jul 13; 13(7):425-31. PubMed ID: 17620038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.